Analysis Forecast Business Coronavirus Featured Headlines Marketing News Technology

Wearable Injectors Market Size Expected To Experience Immense Growth During 2020-2027 | Amgen, Insulet, Cequr

A report by The Insight Partner’s on the global Wearable Injectors market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market by monitoring the strengths and weaknesses of prominent contributors and their key products.

Wearable injectors are drug delivery devices adhering to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors. The devices consist of a reservoir for medicine, a cannula for substance delivery to tissues, and a drive system to deliver the appropriate drug volume; it is loaded with adhesive to fix the device to the patients’ skin. The growth of the wearable injector market is attributed to the increasing chronic disease prevalence, technological advancements and design development, and conventional drug delivery system limitations, among others. However, the lack of adoption in emerging countries limits the market growth. Further, the increasing demand for biologics is a significant opportunity for the global wearable injectors market players.

Request for sample PDF Copy @

What’s included:

  • Market Dynamics
  • Competitive Analysis
  • Market Trends And Market Outlook
  • Market Share And Market Size
  • Opportunities And Customer Analysis
  • Product Pricing Research

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior & the growth of the market as well as industries.

Based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors. In 2019, the on-body injectors segment accounted for a larger share of the global wearable injectors market. On-body injectors ensure comfort and ease of useconfer water resistance and flexible dosing features, and facilitate automatic warming of refrigerated drugs. These benefits have led to the rise in demand for on-body injectors. Moreover, the market for off-body injectors is expected to grow at a faster pace during the forecast period, and the projected growth is attributed to the fact that these devices are free of the risks of skin fitting issues and allergic skin reactions.

Wearable injectors are rapidly gaining their prominence in the market owing to their capabilities in delivering a high volume of viscous formulations. The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings. Self-administration of subcutaneous injections is expected to save 30–70% of costs. Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries. The rise in the number of biologic drugs that are not suitable for oral administration has increased the adoption of wearable injection devices. Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods such as wearable injectors. For instance, the enFuse wearable injector manufactured by Enable Injections is used for subcutaneous delivery of high-volume therapeutics outside a healthcare facility. The company has also introduced mobile monitoring and more significant volume capabilities to its high-volume wearable injectors.


By Type

  • On-body Injectors
  • Off-body Injectors

By Application

  • Diabetes
  • Oncology
  • Cardiovascular Disease
  • Autoimmune Disease
  • Other Applications

By End User

  • Hospitals and Clinics
  • Homecare Setting
  • Other End User

The COVID-19 outbreak is currently going the world over, the Wearable Injectors Market report covers the impact of the corona-virus on top company’s growth. This research report categorizes as the key players in the Wearable Injectors market and also gives a comprehensive study of Covid-19 impact analysis of the market by regions like (Americas, Europe APAC, and EMEA).

The report offers key drivers that propel the growth in the global Wearable Injectors market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions.

A few leading companies operating in the global Wearable Injectors market are:

  • Amgen, Inc.
  • Medtronic
  • BD
  • Insulet Corporation
  • Gerresheimer AG (Sensile Medical)
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG,
  • Tandem Diabetes Care, Inc.
  • Cequr SA
  • Debiotech S.A
  • E3D Elcam Drug Delivery Devices
  • Zealand Pharma A/S (Valeritas, Inc.)

This report focuses on the global Wearable Injectors market with the future forecast, growth opportunity, key market, and key players. The study objectives are to present the Wearable Injectors market development in North America, Europe, China, Japan, Southeast Asia, India, and Central & South America.

Purchase Copy of This Report at

About us: –

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact us: –

Call: +1-646-491-9876

Email: [email protected]